It’s been a big two weeks for medical technology researcher Becton, Dickinson, and Company (NYSE:BDX). Not only did the company post better-than-expected results for its fiscal second quarter, but it has also announced a major acquisition.
Becton, Dickinson has reached a deal to acquire medical supply giant C.R. Bard (NYSE:BCR) for $24 billion.
